Yesterday, the U.S. Department of Health and Human Services finalized a rule expanding short-term, limited-duration insurance plans -- threatening access to adequate, affordable coverage for people with cystic fibrosis who rely on the individual marketplace.
Site Search
Showing 1 - 10 of 28 results
News
|
|
2 min read
News
|
|
3 min read
News
|
|
2 min read
News
|
|
2 min read
News
|
|
1 min read
News
|
|
2 min read
A new inhaled antibiotic for the treatment of cystic fibrosis called Cayston® is now available for patients through select specialty pharmacies, including the CF Services Pharmacy.
News
|
|
2 min read
A key focus of this year's North American Cystic Fibrosis Conference (NACFC) was the progress of the more than 30 potential new therapies moving through the CF Foundation's drug development pipeline.
News
|
|
2 min read
On March 20, the Cystic Fibrosis Foundation and 86 other organizations called on Congress to protect Medicaid, a critical source of coverage for people in the cystic fibrosis community.
News
|
|
2 min read
CF Foundation's $1 Million Investment Helped Drug Known as Cayston® Become a Reality
Press Release
|
|
4 min read